ANNALS OF CLINICAL AND LABORATORY SCIENCE-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=801294, encodeId=4aaa80129474, content=投了三个多月，中间催了两次，说在under review，现在仍然没有消息，这是什么鬼啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150928/IMG5608CD12CF3009910.jpg, createdBy=2e761652994, createdName=海上飘星, createdTime=Sun Jul 05 10:55:30 CST 2020, time=2020-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2121989, encodeId=04fe21219896b, content=这个杂志的文章怎么都没有doi啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d02d8107809, createdName=ms9000000001550341, createdTime=Sun Mar 26 23:07:49 CST 2023, time=2023-03-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2110877, encodeId=b1dc21108e700, content=这个杂志的投稿链接是哪里啊？找半天找不到。。。，有哪位大神知道，指点指点一下，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70614861774, createdName=shengbin117, createdTime=Thu Jan 19 19:38:39 CST 2023, time=2023-01-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1220227, encodeId=7e7d122022e64, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：免疫;肿瘤;基础 经验分享：已投被拒，建议投更专业的杂志，婉拒吧，挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f05623291, createdName=ms5000001157259702, createdTime=Tue May 17 09:54:10 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588195, encodeId=bd50588195c8, content=说研究内容陈旧，前言里有一句话说法是错的，感觉审稿人很不正规。但是人家的退稿意见倒是做成很正式的感觉:官方的logo，还做成像一封信的样子的附件。。。我是该高兴呢，还是高兴呢？海上飘星 2020-03-16 00:00:00 发表: 有什么审稿意见吗？谢谢。, beContent=海上飘星 2020-03-16 00:00:00 发表: 有什么审稿意见吗？谢谢。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230612/3eecdedc6c54489589f75c043e297f5a/5f4431cc3c6f4e7198a3e9664cca766d.jpg, createdBy=600c102391, createdName=zhanghenhao, createdTime=Sun Apr 05 00:00:00 CST 2020, time=2020-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211371, encodeId=290812113e1ba, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：投了一篇纯细胞的实验，中午投下午就拒了，说是内容不符合本杂志，效率还是很高的，没有耽误时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f05623291, createdName=ms5000001157259702, createdTime=Fri Apr 15 09:52:38 CST 2022, time=2022-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213196, encodeId=d9ed12131966e, content=这个期刊不能有共同一作吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c7c85517273, createdName=shyhxyxz1005, createdTime=Thu Apr 21 16:14:18 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218878, encodeId=c5bf12188e816, content=接受临床病例分析么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d088154040, createdName=ms3000001846552432, createdTime=Wed May 11 22:01:48 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078230, encodeId=5ac410e8230a0, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:600.0 偏重的研究方向：肿瘤;基础 经验分享：急的毕业或课题结题可以考虑，比较快接受，也比较快见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=20151619752, createdName=lucas1, createdTime=Wed Dec 08 22:28:08 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573666, encodeId=731a5e3666de, content=请问大神参考文献的格式怎么修改我从 endnote上找不到参考文献的模板求助mayaxlj 2018-12-06 00:00:00 发表: 10.12用126邮箱投稿一次，48小时内没有收到“稿件确认通知”，10.14再次126邮箱投稿，依旧48小时内没有收到通知，10.16改用qq邮箱投稿，10.18收到确认通知。11.27收到小修通知，12.5修改好再次投出，12.6收到接收通知。这个杂志是目前是邮箱投稿，没有网上投稿系统。, beContent=mayaxlj 2018-12-06 00:00:00 发表: 10.12用126邮箱投稿一次，48小时内没有收到“稿件确认通知”，10.14再次126邮箱投稿，依旧48小时内没有收到通知，10.16改用qq邮箱投稿，10.18收到确认通知。11.27收到小修通知，12.5修改好再次投出，12.6收到接收通知。这个杂志是目前是邮箱投稿，没有网上投稿系统。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61d62286837, createdName=121d9982m19暂无昵称, createdTime=Sun Jul 14 00:00:00 CST 2019, time=2019-07-14, status=1, ipAttribution=)]

2020-07-05 海上飘星

投了三个多月，中间催了两次，说在under review，现在仍然没有消息，这是什么鬼啊？

144 11

展开11条回复

[GetPortalCommentsPageByObjectIdResponse(id=801294, encodeId=4aaa80129474, content=投了三个多月，中间催了两次，说在under review，现在仍然没有消息，这是什么鬼啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150928/IMG5608CD12CF3009910.jpg, createdBy=2e761652994, createdName=海上飘星, createdTime=Sun Jul 05 10:55:30 CST 2020, time=2020-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2121989, encodeId=04fe21219896b, content=这个杂志的文章怎么都没有doi啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d02d8107809, createdName=ms9000000001550341, createdTime=Sun Mar 26 23:07:49 CST 2023, time=2023-03-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2110877, encodeId=b1dc21108e700, content=这个杂志的投稿链接是哪里啊？找半天找不到。。。，有哪位大神知道，指点指点一下，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70614861774, createdName=shengbin117, createdTime=Thu Jan 19 19:38:39 CST 2023, time=2023-01-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1220227, encodeId=7e7d122022e64, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：免疫;肿瘤;基础 经验分享：已投被拒，建议投更专业的杂志，婉拒吧，挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f05623291, createdName=ms5000001157259702, createdTime=Tue May 17 09:54:10 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588195, encodeId=bd50588195c8, content=说研究内容陈旧，前言里有一句话说法是错的，感觉审稿人很不正规。但是人家的退稿意见倒是做成很正式的感觉:官方的logo，还做成像一封信的样子的附件。。。我是该高兴呢，还是高兴呢？海上飘星 2020-03-16 00:00:00 发表: 有什么审稿意见吗？谢谢。, beContent=海上飘星 2020-03-16 00:00:00 发表: 有什么审稿意见吗？谢谢。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230612/3eecdedc6c54489589f75c043e297f5a/5f4431cc3c6f4e7198a3e9664cca766d.jpg, createdBy=600c102391, createdName=zhanghenhao, createdTime=Sun Apr 05 00:00:00 CST 2020, time=2020-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211371, encodeId=290812113e1ba, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：投了一篇纯细胞的实验，中午投下午就拒了，说是内容不符合本杂志，效率还是很高的，没有耽误时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f05623291, createdName=ms5000001157259702, createdTime=Fri Apr 15 09:52:38 CST 2022, time=2022-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213196, encodeId=d9ed12131966e, content=这个期刊不能有共同一作吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c7c85517273, createdName=shyhxyxz1005, createdTime=Thu Apr 21 16:14:18 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218878, encodeId=c5bf12188e816, content=接受临床病例分析么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d088154040, createdName=ms3000001846552432, createdTime=Wed May 11 22:01:48 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078230, encodeId=5ac410e8230a0, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:600.0 偏重的研究方向：肿瘤;基础 经验分享：急的毕业或课题结题可以考虑，比较快接受，也比较快见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=20151619752, createdName=lucas1, createdTime=Wed Dec 08 22:28:08 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573666, encodeId=731a5e3666de, content=请问大神参考文献的格式怎么修改我从 endnote上找不到参考文献的模板求助mayaxlj 2018-12-06 00:00:00 发表: 10.12用126邮箱投稿一次，48小时内没有收到“稿件确认通知”，10.14再次126邮箱投稿，依旧48小时内没有收到通知，10.16改用qq邮箱投稿，10.18收到确认通知。11.27收到小修通知，12.5修改好再次投出，12.6收到接收通知。这个杂志是目前是邮箱投稿，没有网上投稿系统。, beContent=mayaxlj 2018-12-06 00:00:00 发表: 10.12用126邮箱投稿一次，48小时内没有收到“稿件确认通知”，10.14再次126邮箱投稿，依旧48小时内没有收到通知，10.16改用qq邮箱投稿，10.18收到确认通知。11.27收到小修通知，12.5修改好再次投出，12.6收到接收通知。这个杂志是目前是邮箱投稿，没有网上投稿系统。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61d62286837, createdName=121d9982m19暂无昵称, createdTime=Sun Jul 14 00:00:00 CST 2019, time=2019-07-14, status=1, ipAttribution=)]

2023-03-26 ms9000000001550341 来自浙江省

这个杂志的文章怎么都没有doi啊？

32 0

[GetPortalCommentsPageByObjectIdResponse(id=801294, encodeId=4aaa80129474, content=投了三个多月，中间催了两次，说在under review，现在仍然没有消息，这是什么鬼啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150928/IMG5608CD12CF3009910.jpg, createdBy=2e761652994, createdName=海上飘星, createdTime=Sun Jul 05 10:55:30 CST 2020, time=2020-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2121989, encodeId=04fe21219896b, content=这个杂志的文章怎么都没有doi啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d02d8107809, createdName=ms9000000001550341, createdTime=Sun Mar 26 23:07:49 CST 2023, time=2023-03-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2110877, encodeId=b1dc21108e700, content=这个杂志的投稿链接是哪里啊？找半天找不到。。。，有哪位大神知道，指点指点一下，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70614861774, createdName=shengbin117, createdTime=Thu Jan 19 19:38:39 CST 2023, time=2023-01-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1220227, encodeId=7e7d122022e64, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：免疫;肿瘤;基础 经验分享：已投被拒，建议投更专业的杂志，婉拒吧，挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f05623291, createdName=ms5000001157259702, createdTime=Tue May 17 09:54:10 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588195, encodeId=bd50588195c8, content=说研究内容陈旧，前言里有一句话说法是错的，感觉审稿人很不正规。但是人家的退稿意见倒是做成很正式的感觉:官方的logo，还做成像一封信的样子的附件。。。我是该高兴呢，还是高兴呢？海上飘星 2020-03-16 00:00:00 发表: 有什么审稿意见吗？谢谢。, beContent=海上飘星 2020-03-16 00:00:00 发表: 有什么审稿意见吗？谢谢。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230612/3eecdedc6c54489589f75c043e297f5a/5f4431cc3c6f4e7198a3e9664cca766d.jpg, createdBy=600c102391, createdName=zhanghenhao, createdTime=Sun Apr 05 00:00:00 CST 2020, time=2020-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211371, encodeId=290812113e1ba, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：投了一篇纯细胞的实验，中午投下午就拒了，说是内容不符合本杂志，效率还是很高的，没有耽误时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f05623291, createdName=ms5000001157259702, createdTime=Fri Apr 15 09:52:38 CST 2022, time=2022-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213196, encodeId=d9ed12131966e, content=这个期刊不能有共同一作吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c7c85517273, createdName=shyhxyxz1005, createdTime=Thu Apr 21 16:14:18 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218878, encodeId=c5bf12188e816, content=接受临床病例分析么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d088154040, createdName=ms3000001846552432, createdTime=Wed May 11 22:01:48 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078230, encodeId=5ac410e8230a0, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:600.0 偏重的研究方向：肿瘤;基础 经验分享：急的毕业或课题结题可以考虑，比较快接受，也比较快见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=20151619752, createdName=lucas1, createdTime=Wed Dec 08 22:28:08 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573666, encodeId=731a5e3666de, content=请问大神参考文献的格式怎么修改我从 endnote上找不到参考文献的模板求助mayaxlj 2018-12-06 00:00:00 发表: 10.12用126邮箱投稿一次，48小时内没有收到“稿件确认通知”，10.14再次126邮箱投稿，依旧48小时内没有收到通知，10.16改用qq邮箱投稿，10.18收到确认通知。11.27收到小修通知，12.5修改好再次投出，12.6收到接收通知。这个杂志是目前是邮箱投稿，没有网上投稿系统。, beContent=mayaxlj 2018-12-06 00:00:00 发表: 10.12用126邮箱投稿一次，48小时内没有收到“稿件确认通知”，10.14再次126邮箱投稿，依旧48小时内没有收到通知，10.16改用qq邮箱投稿，10.18收到确认通知。11.27收到小修通知，12.5修改好再次投出，12.6收到接收通知。这个杂志是目前是邮箱投稿，没有网上投稿系统。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61d62286837, createdName=121d9982m19暂无昵称, createdTime=Sun Jul 14 00:00:00 CST 2019, time=2019-07-14, status=1, ipAttribution=)]

2023-01-19 shengbin117 来自江苏省

这个杂志的投稿链接是哪里啊？找半天找不到。。。，有哪位大神知道，指点指点一下，谢谢

51 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=801294, encodeId=4aaa80129474, content=投了三个多月，中间催了两次，说在under review，现在仍然没有消息，这是什么鬼啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150928/IMG5608CD12CF3009910.jpg, createdBy=2e761652994, createdName=海上飘星, createdTime=Sun Jul 05 10:55:30 CST 2020, time=2020-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2121989, encodeId=04fe21219896b, content=这个杂志的文章怎么都没有doi啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d02d8107809, createdName=ms9000000001550341, createdTime=Sun Mar 26 23:07:49 CST 2023, time=2023-03-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2110877, encodeId=b1dc21108e700, content=这个杂志的投稿链接是哪里啊？找半天找不到。。。，有哪位大神知道，指点指点一下，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70614861774, createdName=shengbin117, createdTime=Thu Jan 19 19:38:39 CST 2023, time=2023-01-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1220227, encodeId=7e7d122022e64, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：免疫;肿瘤;基础 经验分享：已投被拒，建议投更专业的杂志，婉拒吧，挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f05623291, createdName=ms5000001157259702, createdTime=Tue May 17 09:54:10 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588195, encodeId=bd50588195c8, content=说研究内容陈旧，前言里有一句话说法是错的，感觉审稿人很不正规。但是人家的退稿意见倒是做成很正式的感觉:官方的logo，还做成像一封信的样子的附件。。。我是该高兴呢，还是高兴呢？海上飘星 2020-03-16 00:00:00 发表: 有什么审稿意见吗？谢谢。, beContent=海上飘星 2020-03-16 00:00:00 发表: 有什么审稿意见吗？谢谢。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230612/3eecdedc6c54489589f75c043e297f5a/5f4431cc3c6f4e7198a3e9664cca766d.jpg, createdBy=600c102391, createdName=zhanghenhao, createdTime=Sun Apr 05 00:00:00 CST 2020, time=2020-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211371, encodeId=290812113e1ba, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：投了一篇纯细胞的实验，中午投下午就拒了，说是内容不符合本杂志，效率还是很高的，没有耽误时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f05623291, createdName=ms5000001157259702, createdTime=Fri Apr 15 09:52:38 CST 2022, time=2022-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213196, encodeId=d9ed12131966e, content=这个期刊不能有共同一作吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c7c85517273, createdName=shyhxyxz1005, createdTime=Thu Apr 21 16:14:18 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218878, encodeId=c5bf12188e816, content=接受临床病例分析么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d088154040, createdName=ms3000001846552432, createdTime=Wed May 11 22:01:48 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078230, encodeId=5ac410e8230a0, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:600.0 偏重的研究方向：肿瘤;基础 经验分享：急的毕业或课题结题可以考虑，比较快接受，也比较快见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=20151619752, createdName=lucas1, createdTime=Wed Dec 08 22:28:08 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573666, encodeId=731a5e3666de, content=请问大神参考文献的格式怎么修改我从 endnote上找不到参考文献的模板求助mayaxlj 2018-12-06 00:00:00 发表: 10.12用126邮箱投稿一次，48小时内没有收到“稿件确认通知”，10.14再次126邮箱投稿，依旧48小时内没有收到通知，10.16改用qq邮箱投稿，10.18收到确认通知。11.27收到小修通知，12.5修改好再次投出，12.6收到接收通知。这个杂志是目前是邮箱投稿，没有网上投稿系统。, beContent=mayaxlj 2018-12-06 00:00:00 发表: 10.12用126邮箱投稿一次，48小时内没有收到“稿件确认通知”，10.14再次126邮箱投稿，依旧48小时内没有收到通知，10.16改用qq邮箱投稿，10.18收到确认通知。11.27收到小修通知，12.5修改好再次投出，12.6收到接收通知。这个杂志是目前是邮箱投稿，没有网上投稿系统。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61d62286837, createdName=121d9982m19暂无昵称, createdTime=Sun Jul 14 00:00:00 CST 2019, time=2019-07-14, status=1, ipAttribution=)]

2022-05-17 ms5000001157259702

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：免疫;肿瘤;基础
经验分享：已投被拒，建议投更专业的杂志，婉拒吧，挺快的

49 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=801294, encodeId=4aaa80129474, content=投了三个多月，中间催了两次，说在under review，现在仍然没有消息，这是什么鬼啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150928/IMG5608CD12CF3009910.jpg, createdBy=2e761652994, createdName=海上飘星, createdTime=Sun Jul 05 10:55:30 CST 2020, time=2020-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2121989, encodeId=04fe21219896b, content=这个杂志的文章怎么都没有doi啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d02d8107809, createdName=ms9000000001550341, createdTime=Sun Mar 26 23:07:49 CST 2023, time=2023-03-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2110877, encodeId=b1dc21108e700, content=这个杂志的投稿链接是哪里啊？找半天找不到。。。，有哪位大神知道，指点指点一下，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70614861774, createdName=shengbin117, createdTime=Thu Jan 19 19:38:39 CST 2023, time=2023-01-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1220227, encodeId=7e7d122022e64, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：免疫;肿瘤;基础 经验分享：已投被拒，建议投更专业的杂志，婉拒吧，挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f05623291, createdName=ms5000001157259702, createdTime=Tue May 17 09:54:10 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588195, encodeId=bd50588195c8, content=说研究内容陈旧，前言里有一句话说法是错的，感觉审稿人很不正规。但是人家的退稿意见倒是做成很正式的感觉:官方的logo，还做成像一封信的样子的附件。。。我是该高兴呢，还是高兴呢？海上飘星 2020-03-16 00:00:00 发表: 有什么审稿意见吗？谢谢。, beContent=海上飘星 2020-03-16 00:00:00 发表: 有什么审稿意见吗？谢谢。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230612/3eecdedc6c54489589f75c043e297f5a/5f4431cc3c6f4e7198a3e9664cca766d.jpg, createdBy=600c102391, createdName=zhanghenhao, createdTime=Sun Apr 05 00:00:00 CST 2020, time=2020-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211371, encodeId=290812113e1ba, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：投了一篇纯细胞的实验，中午投下午就拒了，说是内容不符合本杂志，效率还是很高的，没有耽误时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f05623291, createdName=ms5000001157259702, createdTime=Fri Apr 15 09:52:38 CST 2022, time=2022-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213196, encodeId=d9ed12131966e, content=这个期刊不能有共同一作吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c7c85517273, createdName=shyhxyxz1005, createdTime=Thu Apr 21 16:14:18 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218878, encodeId=c5bf12188e816, content=接受临床病例分析么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d088154040, createdName=ms3000001846552432, createdTime=Wed May 11 22:01:48 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078230, encodeId=5ac410e8230a0, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:600.0 偏重的研究方向：肿瘤;基础 经验分享：急的毕业或课题结题可以考虑，比较快接受，也比较快见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=20151619752, createdName=lucas1, createdTime=Wed Dec 08 22:28:08 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573666, encodeId=731a5e3666de, content=请问大神参考文献的格式怎么修改我从 endnote上找不到参考文献的模板求助mayaxlj 2018-12-06 00:00:00 发表: 10.12用126邮箱投稿一次，48小时内没有收到“稿件确认通知”，10.14再次126邮箱投稿，依旧48小时内没有收到通知，10.16改用qq邮箱投稿，10.18收到确认通知。11.27收到小修通知，12.5修改好再次投出，12.6收到接收通知。这个杂志是目前是邮箱投稿，没有网上投稿系统。, beContent=mayaxlj 2018-12-06 00:00:00 发表: 10.12用126邮箱投稿一次，48小时内没有收到“稿件确认通知”，10.14再次126邮箱投稿，依旧48小时内没有收到通知，10.16改用qq邮箱投稿，10.18收到确认通知。11.27收到小修通知，12.5修改好再次投出，12.6收到接收通知。这个杂志是目前是邮箱投稿，没有网上投稿系统。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61d62286837, createdName=121d9982m19暂无昵称, createdTime=Sun Jul 14 00:00:00 CST 2019, time=2019-07-14, status=1, ipAttribution=)]

2020-04-05 zhanghenhao

说研究内容陈旧，前言里有一句话说法是错的，感觉审稿人很不正规。但是人家的退稿意见倒是做成很正式的感觉:官方的logo，还做成像一封信的样子的附件。。。我是该高兴呢，还是高兴呢？海上飘星 2020-03-16 00:00:00 发表:
有什么审稿意见吗？谢谢。

海上飘星 2020-03-16 00:00:00 发表: 有什么审稿意见吗？谢谢。

150 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=801294, encodeId=4aaa80129474, content=投了三个多月，中间催了两次，说在under review，现在仍然没有消息，这是什么鬼啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150928/IMG5608CD12CF3009910.jpg, createdBy=2e761652994, createdName=海上飘星, createdTime=Sun Jul 05 10:55:30 CST 2020, time=2020-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2121989, encodeId=04fe21219896b, content=这个杂志的文章怎么都没有doi啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d02d8107809, createdName=ms9000000001550341, createdTime=Sun Mar 26 23:07:49 CST 2023, time=2023-03-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2110877, encodeId=b1dc21108e700, content=这个杂志的投稿链接是哪里啊？找半天找不到。。。，有哪位大神知道，指点指点一下，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70614861774, createdName=shengbin117, createdTime=Thu Jan 19 19:38:39 CST 2023, time=2023-01-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1220227, encodeId=7e7d122022e64, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：免疫;肿瘤;基础 经验分享：已投被拒，建议投更专业的杂志，婉拒吧，挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f05623291, createdName=ms5000001157259702, createdTime=Tue May 17 09:54:10 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588195, encodeId=bd50588195c8, content=说研究内容陈旧，前言里有一句话说法是错的，感觉审稿人很不正规。但是人家的退稿意见倒是做成很正式的感觉:官方的logo，还做成像一封信的样子的附件。。。我是该高兴呢，还是高兴呢？海上飘星 2020-03-16 00:00:00 发表: 有什么审稿意见吗？谢谢。, beContent=海上飘星 2020-03-16 00:00:00 发表: 有什么审稿意见吗？谢谢。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230612/3eecdedc6c54489589f75c043e297f5a/5f4431cc3c6f4e7198a3e9664cca766d.jpg, createdBy=600c102391, createdName=zhanghenhao, createdTime=Sun Apr 05 00:00:00 CST 2020, time=2020-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211371, encodeId=290812113e1ba, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：投了一篇纯细胞的实验，中午投下午就拒了，说是内容不符合本杂志，效率还是很高的，没有耽误时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f05623291, createdName=ms5000001157259702, createdTime=Fri Apr 15 09:52:38 CST 2022, time=2022-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213196, encodeId=d9ed12131966e, content=这个期刊不能有共同一作吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c7c85517273, createdName=shyhxyxz1005, createdTime=Thu Apr 21 16:14:18 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218878, encodeId=c5bf12188e816, content=接受临床病例分析么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d088154040, createdName=ms3000001846552432, createdTime=Wed May 11 22:01:48 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078230, encodeId=5ac410e8230a0, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:600.0 偏重的研究方向：肿瘤;基础 经验分享：急的毕业或课题结题可以考虑，比较快接受，也比较快见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=20151619752, createdName=lucas1, createdTime=Wed Dec 08 22:28:08 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573666, encodeId=731a5e3666de, content=请问大神参考文献的格式怎么修改我从 endnote上找不到参考文献的模板求助mayaxlj 2018-12-06 00:00:00 发表: 10.12用126邮箱投稿一次，48小时内没有收到“稿件确认通知”，10.14再次126邮箱投稿，依旧48小时内没有收到通知，10.16改用qq邮箱投稿，10.18收到确认通知。11.27收到小修通知，12.5修改好再次投出，12.6收到接收通知。这个杂志是目前是邮箱投稿，没有网上投稿系统。, beContent=mayaxlj 2018-12-06 00:00:00 发表: 10.12用126邮箱投稿一次，48小时内没有收到“稿件确认通知”，10.14再次126邮箱投稿，依旧48小时内没有收到通知，10.16改用qq邮箱投稿，10.18收到确认通知。11.27收到小修通知，12.5修改好再次投出，12.6收到接收通知。这个杂志是目前是邮箱投稿，没有网上投稿系统。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61d62286837, createdName=121d9982m19暂无昵称, createdTime=Sun Jul 14 00:00:00 CST 2019, time=2019-07-14, status=1, ipAttribution=)]

2022-04-15 ms5000001157259702

审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向：肿瘤
经验分享：投了一篇纯细胞的实验，中午投下午就拒了，说是内容不符合本杂志，效率还是很高的，没有耽误时间

55 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=801294, encodeId=4aaa80129474, content=投了三个多月，中间催了两次，说在under review，现在仍然没有消息，这是什么鬼啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150928/IMG5608CD12CF3009910.jpg, createdBy=2e761652994, createdName=海上飘星, createdTime=Sun Jul 05 10:55:30 CST 2020, time=2020-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2121989, encodeId=04fe21219896b, content=这个杂志的文章怎么都没有doi啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d02d8107809, createdName=ms9000000001550341, createdTime=Sun Mar 26 23:07:49 CST 2023, time=2023-03-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2110877, encodeId=b1dc21108e700, content=这个杂志的投稿链接是哪里啊？找半天找不到。。。，有哪位大神知道，指点指点一下，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70614861774, createdName=shengbin117, createdTime=Thu Jan 19 19:38:39 CST 2023, time=2023-01-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1220227, encodeId=7e7d122022e64, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：免疫;肿瘤;基础 经验分享：已投被拒，建议投更专业的杂志，婉拒吧，挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f05623291, createdName=ms5000001157259702, createdTime=Tue May 17 09:54:10 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588195, encodeId=bd50588195c8, content=说研究内容陈旧，前言里有一句话说法是错的，感觉审稿人很不正规。但是人家的退稿意见倒是做成很正式的感觉:官方的logo，还做成像一封信的样子的附件。。。我是该高兴呢，还是高兴呢？海上飘星 2020-03-16 00:00:00 发表: 有什么审稿意见吗？谢谢。, beContent=海上飘星 2020-03-16 00:00:00 发表: 有什么审稿意见吗？谢谢。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230612/3eecdedc6c54489589f75c043e297f5a/5f4431cc3c6f4e7198a3e9664cca766d.jpg, createdBy=600c102391, createdName=zhanghenhao, createdTime=Sun Apr 05 00:00:00 CST 2020, time=2020-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211371, encodeId=290812113e1ba, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：投了一篇纯细胞的实验，中午投下午就拒了，说是内容不符合本杂志，效率还是很高的，没有耽误时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f05623291, createdName=ms5000001157259702, createdTime=Fri Apr 15 09:52:38 CST 2022, time=2022-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213196, encodeId=d9ed12131966e, content=这个期刊不能有共同一作吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c7c85517273, createdName=shyhxyxz1005, createdTime=Thu Apr 21 16:14:18 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218878, encodeId=c5bf12188e816, content=接受临床病例分析么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d088154040, createdName=ms3000001846552432, createdTime=Wed May 11 22:01:48 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078230, encodeId=5ac410e8230a0, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:600.0 偏重的研究方向：肿瘤;基础 经验分享：急的毕业或课题结题可以考虑，比较快接受，也比较快见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=20151619752, createdName=lucas1, createdTime=Wed Dec 08 22:28:08 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573666, encodeId=731a5e3666de, content=请问大神参考文献的格式怎么修改我从 endnote上找不到参考文献的模板求助mayaxlj 2018-12-06 00:00:00 发表: 10.12用126邮箱投稿一次，48小时内没有收到“稿件确认通知”，10.14再次126邮箱投稿，依旧48小时内没有收到通知，10.16改用qq邮箱投稿，10.18收到确认通知。11.27收到小修通知，12.5修改好再次投出，12.6收到接收通知。这个杂志是目前是邮箱投稿，没有网上投稿系统。, beContent=mayaxlj 2018-12-06 00:00:00 发表: 10.12用126邮箱投稿一次，48小时内没有收到“稿件确认通知”，10.14再次126邮箱投稿，依旧48小时内没有收到通知，10.16改用qq邮箱投稿，10.18收到确认通知。11.27收到小修通知，12.5修改好再次投出，12.6收到接收通知。这个杂志是目前是邮箱投稿，没有网上投稿系统。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61d62286837, createdName=121d9982m19暂无昵称, createdTime=Sun Jul 14 00:00:00 CST 2019, time=2019-07-14, status=1, ipAttribution=)]

2022-04-21 shyhxyxz1005

这个期刊不能有共同一作吗？

59 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=801294, encodeId=4aaa80129474, content=投了三个多月，中间催了两次，说在under review，现在仍然没有消息，这是什么鬼啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150928/IMG5608CD12CF3009910.jpg, createdBy=2e761652994, createdName=海上飘星, createdTime=Sun Jul 05 10:55:30 CST 2020, time=2020-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2121989, encodeId=04fe21219896b, content=这个杂志的文章怎么都没有doi啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d02d8107809, createdName=ms9000000001550341, createdTime=Sun Mar 26 23:07:49 CST 2023, time=2023-03-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2110877, encodeId=b1dc21108e700, content=这个杂志的投稿链接是哪里啊？找半天找不到。。。，有哪位大神知道，指点指点一下，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70614861774, createdName=shengbin117, createdTime=Thu Jan 19 19:38:39 CST 2023, time=2023-01-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1220227, encodeId=7e7d122022e64, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：免疫;肿瘤;基础 经验分享：已投被拒，建议投更专业的杂志，婉拒吧，挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f05623291, createdName=ms5000001157259702, createdTime=Tue May 17 09:54:10 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588195, encodeId=bd50588195c8, content=说研究内容陈旧，前言里有一句话说法是错的，感觉审稿人很不正规。但是人家的退稿意见倒是做成很正式的感觉:官方的logo，还做成像一封信的样子的附件。。。我是该高兴呢，还是高兴呢？海上飘星 2020-03-16 00:00:00 发表: 有什么审稿意见吗？谢谢。, beContent=海上飘星 2020-03-16 00:00:00 发表: 有什么审稿意见吗？谢谢。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230612/3eecdedc6c54489589f75c043e297f5a/5f4431cc3c6f4e7198a3e9664cca766d.jpg, createdBy=600c102391, createdName=zhanghenhao, createdTime=Sun Apr 05 00:00:00 CST 2020, time=2020-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211371, encodeId=290812113e1ba, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：投了一篇纯细胞的实验，中午投下午就拒了，说是内容不符合本杂志，效率还是很高的，没有耽误时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f05623291, createdName=ms5000001157259702, createdTime=Fri Apr 15 09:52:38 CST 2022, time=2022-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213196, encodeId=d9ed12131966e, content=这个期刊不能有共同一作吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c7c85517273, createdName=shyhxyxz1005, createdTime=Thu Apr 21 16:14:18 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218878, encodeId=c5bf12188e816, content=接受临床病例分析么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d088154040, createdName=ms3000001846552432, createdTime=Wed May 11 22:01:48 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078230, encodeId=5ac410e8230a0, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:600.0 偏重的研究方向：肿瘤;基础 经验分享：急的毕业或课题结题可以考虑，比较快接受，也比较快见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=20151619752, createdName=lucas1, createdTime=Wed Dec 08 22:28:08 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573666, encodeId=731a5e3666de, content=请问大神参考文献的格式怎么修改我从 endnote上找不到参考文献的模板求助mayaxlj 2018-12-06 00:00:00 发表: 10.12用126邮箱投稿一次，48小时内没有收到“稿件确认通知”，10.14再次126邮箱投稿，依旧48小时内没有收到通知，10.16改用qq邮箱投稿，10.18收到确认通知。11.27收到小修通知，12.5修改好再次投出，12.6收到接收通知。这个杂志是目前是邮箱投稿，没有网上投稿系统。, beContent=mayaxlj 2018-12-06 00:00:00 发表: 10.12用126邮箱投稿一次，48小时内没有收到“稿件确认通知”，10.14再次126邮箱投稿，依旧48小时内没有收到通知，10.16改用qq邮箱投稿，10.18收到确认通知。11.27收到小修通知，12.5修改好再次投出，12.6收到接收通知。这个杂志是目前是邮箱投稿，没有网上投稿系统。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61d62286837, createdName=121d9982m19暂无昵称, createdTime=Sun Jul 14 00:00:00 CST 2019, time=2019-07-14, status=1, ipAttribution=)]

2022-05-11 ms3000001846552432

接受临床病例分析么

81 0

[GetPortalCommentsPageByObjectIdResponse(id=801294, encodeId=4aaa80129474, content=投了三个多月，中间催了两次，说在under review，现在仍然没有消息，这是什么鬼啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150928/IMG5608CD12CF3009910.jpg, createdBy=2e761652994, createdName=海上飘星, createdTime=Sun Jul 05 10:55:30 CST 2020, time=2020-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2121989, encodeId=04fe21219896b, content=这个杂志的文章怎么都没有doi啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d02d8107809, createdName=ms9000000001550341, createdTime=Sun Mar 26 23:07:49 CST 2023, time=2023-03-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2110877, encodeId=b1dc21108e700, content=这个杂志的投稿链接是哪里啊？找半天找不到。。。，有哪位大神知道，指点指点一下，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70614861774, createdName=shengbin117, createdTime=Thu Jan 19 19:38:39 CST 2023, time=2023-01-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1220227, encodeId=7e7d122022e64, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：免疫;肿瘤;基础 经验分享：已投被拒，建议投更专业的杂志，婉拒吧，挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f05623291, createdName=ms5000001157259702, createdTime=Tue May 17 09:54:10 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588195, encodeId=bd50588195c8, content=说研究内容陈旧，前言里有一句话说法是错的，感觉审稿人很不正规。但是人家的退稿意见倒是做成很正式的感觉:官方的logo，还做成像一封信的样子的附件。。。我是该高兴呢，还是高兴呢？海上飘星 2020-03-16 00:00:00 发表: 有什么审稿意见吗？谢谢。, beContent=海上飘星 2020-03-16 00:00:00 发表: 有什么审稿意见吗？谢谢。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230612/3eecdedc6c54489589f75c043e297f5a/5f4431cc3c6f4e7198a3e9664cca766d.jpg, createdBy=600c102391, createdName=zhanghenhao, createdTime=Sun Apr 05 00:00:00 CST 2020, time=2020-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211371, encodeId=290812113e1ba, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：投了一篇纯细胞的实验，中午投下午就拒了，说是内容不符合本杂志，效率还是很高的，没有耽误时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f05623291, createdName=ms5000001157259702, createdTime=Fri Apr 15 09:52:38 CST 2022, time=2022-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213196, encodeId=d9ed12131966e, content=这个期刊不能有共同一作吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c7c85517273, createdName=shyhxyxz1005, createdTime=Thu Apr 21 16:14:18 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218878, encodeId=c5bf12188e816, content=接受临床病例分析么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d088154040, createdName=ms3000001846552432, createdTime=Wed May 11 22:01:48 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078230, encodeId=5ac410e8230a0, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:600.0 偏重的研究方向：肿瘤;基础 经验分享：急的毕业或课题结题可以考虑，比较快接受，也比较快见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=20151619752, createdName=lucas1, createdTime=Wed Dec 08 22:28:08 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573666, encodeId=731a5e3666de, content=请问大神参考文献的格式怎么修改我从 endnote上找不到参考文献的模板求助mayaxlj 2018-12-06 00:00:00 发表: 10.12用126邮箱投稿一次，48小时内没有收到“稿件确认通知”，10.14再次126邮箱投稿，依旧48小时内没有收到通知，10.16改用qq邮箱投稿，10.18收到确认通知。11.27收到小修通知，12.5修改好再次投出，12.6收到接收通知。这个杂志是目前是邮箱投稿，没有网上投稿系统。, beContent=mayaxlj 2018-12-06 00:00:00 发表: 10.12用126邮箱投稿一次，48小时内没有收到“稿件确认通知”，10.14再次126邮箱投稿，依旧48小时内没有收到通知，10.16改用qq邮箱投稿，10.18收到确认通知。11.27收到小修通知，12.5修改好再次投出，12.6收到接收通知。这个杂志是目前是邮箱投稿，没有网上投稿系统。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61d62286837, createdName=121d9982m19暂无昵称, createdTime=Sun Jul 14 00:00:00 CST 2019, time=2019-07-14, status=1, ipAttribution=)]

2021-12-08 lucas1

审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:600.0
偏重的研究方向：肿瘤;基础
经验分享：急的毕业或课题结题可以考虑，比较快接受，也比较快见刊

69 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=801294, encodeId=4aaa80129474, content=投了三个多月，中间催了两次，说在under review，现在仍然没有消息，这是什么鬼啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=144, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150928/IMG5608CD12CF3009910.jpg, createdBy=2e761652994, createdName=海上飘星, createdTime=Sun Jul 05 10:55:30 CST 2020, time=2020-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2121989, encodeId=04fe21219896b, content=这个杂志的文章怎么都没有doi啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d02d8107809, createdName=ms9000000001550341, createdTime=Sun Mar 26 23:07:49 CST 2023, time=2023-03-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2110877, encodeId=b1dc21108e700, content=这个杂志的投稿链接是哪里啊？找半天找不到。。。，有哪位大神知道，指点指点一下，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70614861774, createdName=shengbin117, createdTime=Thu Jan 19 19:38:39 CST 2023, time=2023-01-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1220227, encodeId=7e7d122022e64, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：免疫;肿瘤;基础 经验分享：已投被拒，建议投更专业的杂志，婉拒吧，挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f05623291, createdName=ms5000001157259702, createdTime=Tue May 17 09:54:10 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588195, encodeId=bd50588195c8, content=说研究内容陈旧，前言里有一句话说法是错的，感觉审稿人很不正规。但是人家的退稿意见倒是做成很正式的感觉:官方的logo，还做成像一封信的样子的附件。。。我是该高兴呢，还是高兴呢？海上飘星 2020-03-16 00:00:00 发表: 有什么审稿意见吗？谢谢。, beContent=海上飘星 2020-03-16 00:00:00 发表: 有什么审稿意见吗？谢谢。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230612/3eecdedc6c54489589f75c043e297f5a/5f4431cc3c6f4e7198a3e9664cca766d.jpg, createdBy=600c102391, createdName=zhanghenhao, createdTime=Sun Apr 05 00:00:00 CST 2020, time=2020-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211371, encodeId=290812113e1ba, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：投了一篇纯细胞的实验，中午投下午就拒了，说是内容不符合本杂志，效率还是很高的，没有耽误时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f05623291, createdName=ms5000001157259702, createdTime=Fri Apr 15 09:52:38 CST 2022, time=2022-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213196, encodeId=d9ed12131966e, content=这个期刊不能有共同一作吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c7c85517273, createdName=shyhxyxz1005, createdTime=Thu Apr 21 16:14:18 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1218878, encodeId=c5bf12188e816, content=接受临床病例分析么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4d088154040, createdName=ms3000001846552432, createdTime=Wed May 11 22:01:48 CST 2022, time=2022-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078230, encodeId=5ac410e8230a0, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:600.0 偏重的研究方向：肿瘤;基础 经验分享：急的毕业或课题结题可以考虑，比较快接受，也比较快见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=20151619752, createdName=lucas1, createdTime=Wed Dec 08 22:28:08 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573666, encodeId=731a5e3666de, content=请问大神参考文献的格式怎么修改我从 endnote上找不到参考文献的模板求助mayaxlj 2018-12-06 00:00:00 发表: 10.12用126邮箱投稿一次，48小时内没有收到“稿件确认通知”，10.14再次126邮箱投稿，依旧48小时内没有收到通知，10.16改用qq邮箱投稿，10.18收到确认通知。11.27收到小修通知，12.5修改好再次投出，12.6收到接收通知。这个杂志是目前是邮箱投稿，没有网上投稿系统。, beContent=mayaxlj 2018-12-06 00:00:00 发表: 10.12用126邮箱投稿一次，48小时内没有收到“稿件确认通知”，10.14再次126邮箱投稿，依旧48小时内没有收到通知，10.16改用qq邮箱投稿，10.18收到确认通知。11.27收到小修通知，12.5修改好再次投出，12.6收到接收通知。这个杂志是目前是邮箱投稿，没有网上投稿系统。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=61d62286837, createdName=121d9982m19暂无昵称, createdTime=Sun Jul 14 00:00:00 CST 2019, time=2019-07-14, status=1, ipAttribution=)]

2019-07-14 121d9982m19暂无昵称

请问大神参考文献的格式怎么修改我从 endnote上找不到参考文献的模板求助mayaxlj 2018-12-06 00:00:00 发表:
10.12用126邮箱投稿一次，48小时内没有收到“稿件确认通知”，10.14再次126邮箱投稿，依旧48小时内没有收到通知，10.16改用qq邮箱投稿，10.18收到确认通知。11.27收到小修通知，12.5修改好再次投出，12.6收到接收通知。这个杂志是目前是邮箱投稿，没有网上投稿系统。

mayaxlj 2018-12-06 00:00:00 发表: 10.12用126邮箱投稿一次，48小时内没有收到“稿件确认通知”，10.14再次126邮箱投稿，依旧48小时内没有收到通知，10.16改用qq邮箱投稿，10.18收到确认通知。11.27收到小修通知，12.5修改好再次投出，12.6收到接收通知。这个杂志是目前是邮箱投稿，没有网上投稿系统。

182 2

展开2条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务